Showing results (231-240 of 1,074) with videos related to
Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|October 2, 2023
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outlineAntonios Bayas, Achim Berthele, Norbert Blank, et al.Therapeutic Advances in Neurological Disorders|September 25, 2023
A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximolsClara Grazia Chisari, Joe Guadagno, Peyman Adjamian, et al.Therapeutic Advances in Neurological Disorders|September 7, 2023
Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal seizures: post hoc analysis of a phase III trial and open-label extension studyEugen Trinka, Rodrigo Rocamora, João Chaves, et al.Therapeutic Advances in Neurological Disorders|September 18, 2023
A 20-year multicentre retrospective review of optic nerve sheath fenestration outcomesShaddy El-Masri, Matthew Wilson, Jonathan Goh, et al.Therapeutic Advances in Neurological Disorders|June 26, 2023
Arterial stiffness and its influence on cerebral morphology and cognitive functionMelanie Haidegger, Simon Lindenbeck, Edith Hofer, et al.Therapeutic Advances in Neurological Disorders|March 5, 2026
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practiceAurora Zanghì, Giovanna Borriello, Matteo Foschi, et al.Therapeutic Advances in Neurological Disorders|March 9, 2026
CT perfusion ischemic core predicts PH-2 hemorrhagic transformation following intravenous alteplase bridging treatment prior to endovascular thrombectomyAsaf Honig, Aviva Alpernas, Yoel Schwartzmann, et al.Therapeutic Advances in Neurological Disorders|March 31, 2026
Novel homozygous SYNE1 missense variant in late onset autosomal recessive cerebellar ataxia 1: a case reportIgor Selmaj, Nastassja Himmelreich, Krzysztof SelmajTherapeutic Advances in Neurological Disorders|March 26, 2026
The prospects of CAR T-cell therapies in changing the therapeutic algorithm of neurologic autoimmunitiesMarinos C DalakasTherapeutic Advances in Neurological Disorders|April 8, 2026
Neuroglial markers of damage in autoimmune neurologyAlessandro Dinoto, Sara MariottoPageof 108